ESC Professional Premium Access

Challenges and advances in antithrombotic therapy

Event: ESC Congress 2022
Topic: Anticoagulants
Session type: Moderated ePosters
Date: 26 August 2022
Time: 13:15 - 14:00

Congress Session

7 presentations in this session

A randomized, cross-over study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of milvexian with single and dual antiplatelet therapy in healthy participants

Speaker: Doctor G. Abelian (US)

Effect of low-dose rivaroxaban with low-dose aspirin vs low-dose aspirin on platelet and oxidative biomarkers: a randomized study in diabetes patients with stable peripheral or coronary artery disease

Speaker: Associate Professor B. Rocca (Rome, IT)

Antithrombotic strategies in antiphospholipid syndrome with arterial thrombosis: a systematic review and network meta-analysis

Speaker: Doctor T. Attachaipanich (Chiang Mai, TH)

Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study

Speaker: Doctor K. Matli (Beirut, LB)

CS014 is a novel HDAC inhibitor regulating the platelet activity, fibrinolysis and clot stability for prevention of thrombosis without increased risk of bleeding

Speaker: Associate Professor M. Holinstat (Ann Arbor, US)

Aspirin therapy on prophylactic anticoagulation for hospitalized patients with COVID-19: A propensity score-matched cohort analysis of the HOPE-COVID-19 registry.

Speaker: Doctor F. Santoro (Foggia, IT)

Influence of obesity on the safety and efficacy of antithrombotic therapy: a systematic review and meta-analysis

Speaker: Miss B. Rocha Darze (Salvador, BR)

7 speakers from this session

Doctor Grigor Abelian

, (United States of America)

Associate Professor Bianca Rocca

Catholic University School of Medicine, Rome (Italy)
7 presentations
0 follower

Doctor Tanawat Attachaipanich

Chiang Mai University, Chiang Mai (Thailand)
0 follower

Doctor Kamal Matli

Lebanese American University, Beirut (Lebanon)

Associate Professor Michael Holinstat

University of Michigan, Ann Arbor (United States of America)
0 follower

Doctor Francesco Santoro

University of Foggia, Foggia (Italy)
0 follower

Miss Beatriz Rocha Darze

Bahiana School of Medicine and Public Health, Salvador (Brazil)
0 follower

This platform is supported by

logo Novo Nordisk